Inventor · disambiguated record
Dong Xiao
Also filed as: XIAO DONG
46 granted patents·20 pending applications·369 citations·filing 2000–2025
98Inventor score
Files withMERCK SHARP & DOHME15SCHERING CORP15OPKO HEALTH INC9MERCK SHARP & DOHME LLC7FARSIGHT MEDICAL TECH SHANGHAI CO LTD3
Top patents by PatentIndex Score
66 records- 0194US7884080B2Azetidinone derivatives and methods of use thereofSCHERING PLOUGH CORP·Filed 2007·Granted Feb 8, 2011·46 cites·23 claims
- 0294US7049320B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted May 23, 2006·54 cites·17 claims
- 0394US6635630B2Selective neurokinin antagonistsSCHERING CORP·Filed 2002·Granted Oct 21, 2003·41 cites·9 claims
- 0492US7902366B2NK1 antagonistsOPKO HEALTH INC·Filed 2006·Granted Mar 8, 2011·19 cites·19 claims
- 0592US7709641B2NK1 antagonistsOPKO HEALTH INC·Filed 2005·Granted May 4, 2010·20 cites·30 claims
- 0691US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 0790US9243002B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 0889US8026364B2NK1 antagonistsOPKO HEALTH INC·Filed 2010·Granted Sep 27, 2011·11 cites·39 claims
- 0988US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 1088US8796299B2NK1 antagonistsOPKO HEALTH INC·Filed 2012·Granted Aug 5, 2014·9 cites·15 claims
- 1187US8273895B2NK1 antagonistsPALIWAL SUNIL·Filed 2010·Granted Sep 25, 2012·12 cites·3 claims
- 1287US6436928B1Selective neurokinin antagonistsSCHERING CORP·Filed 2000·Granted Aug 20, 2002·17 cites·23 claims
- 1386US9957219B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·5 cites·13 claims
- 1484US8754216B2NK1 antagonistsSHAH SAPNA S·Filed 2011·Granted Jun 17, 2014·9 cites·38 claims
- 1584US7122677B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted Oct 17, 2006·26 cites·23 claims
- 1683US7763623B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2007·Granted Jul 27, 2010·9 cites·39 claims
- 1782US9242998B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 1881US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 1980US7041682B2NK1 antagonistsSCHERING CORP·Filed 2003·Granted May 9, 2006·14 cites·20 claims
- 2079US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 2179US7354922B2Bridged ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 8, 2008·4 cites·30 claims
- 2278US9469629B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Oct 18, 2016·2 cites·12 claims
- 2378US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 2478US7737155B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2007·Granted Jun 15, 2010·2 cites·35 claims
- 2577US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 2676US6878732B2NK1 antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·10 cites·26 claims
- 2774US7750015B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2006·Granted Jul 6, 2010·2 cites·47 claims
- 2873US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 2972US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 3069US2022378916A1Compounds for reducing the viscosity of biological formulationsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3167US10968193B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Apr 6, 2021·1 cites·11 claims
- 3266US9840512B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·23 claims
- 3364US9688693B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Jun 27, 2017·0 cites·8 claims
- 3464US2018215729A1Nk 1 antagonistsOPKO HEALTH INC·Filed 2018·Application pending·0 cites
- 3563US2025288639A1Treatment and prevention of nephrotoxin-induced kidney injuriesFARSIGHT MEDICAL TECH SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 3662US9969711B2NK1 antagonistsOPKO HEALTH INC·Filed 2016·Granted May 15, 2018·0 cites·6 claims
- 3761US12350310B2Treatment and prevention of nephrotoxin-induced kidney injuriesFARSIGHT MEDICAL TECH SHANGHAI CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·22 claims
- 3861US2017283434A1Nk1 antagonistsOPKO HEALTH INC·Filed 2017·Application pending·0 cites
- 3960US12465629B2Prevention and treatment of organ injuriesFARSIGHT MEDICAL TECH SHANGHAI CO LTD·Filed 2021·Granted Nov 11, 2025·0 cites·20 claims
- 4060US2020206350A1Compounds for reducing the viscosity of biological formulationsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 4157US6887895B2Pseudolaric acid-B derivatives, their preparation and pharmaceutical compositionsSHANGHAI INST MATERIA MEDICA·Filed 2002·Granted May 3, 2005·2 cites·12 claims
- 4257US2025313575A1Macrocycles as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4357US2025099478A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4455US12497362B2Cyclopentapyrrole orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 16, 2025·0 cites·13 claims
- 4555US12492187B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·11 claims
- 4654US2011245267A1Piperidine and piperazine derivatives and methods of use thereofSCHERING PLOUGH CORP·Filed 2009·Application pending·0 cites
- 4753US2011243940A1Bicyclic pyranone derivatives and methods of use thereofSCHERING CORP·Filed 2009·Application pending·0 cites
- 4853US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 4952US11352320B2Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 7, 2022·0 cites·14 claims
- 5052US2023391795A1Macrocyclic urea orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dong Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →